Dulcolax and Catapres drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dulcolax (bisacodyl) and Catapres (clonidine hydrochloride). Common drug interactions include erythema among females and drug dependence among males.

The phase IV clinical study analyzes what interactions people have when they take Dulcolax and Catapres. It is created by eHealthMe based on reports of 61 people who take the same drugs from the FDA, and is updated regularly.

What is Dulcolax?

Dulcolax has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 12,897 Dulcolax users. Check the latest studies of Dulcolax.

What is Catapres?

Catapres has active ingredients of clonidine hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 6,680 Catapres users. Check the latest studies of Catapres.



On Jul, 11, 2026

61 people who take Dulcolax and Catapres together, and have interactions are studied.

Dulcolax and Catapres drug interactions.

What are the common drug interactions of Dulcolax and Catapres, by gender? *:

female:

  1. Erythema (redness of the skin)
  2. Fall
  3. Joint swelling
  4. Respiratory disorder (respiratory disease)
  5. Urinary retention (the inability to completely or partially empty the bladder)
  6. Weight decreased
  7. Headache (pain in head)
  8. Abscess oral (abscess in the mouth)
  9. Actinomycosis (infection that causes sores, or abscesses)
  10. Anaemia (lack of blood)

male:

  1. Drug dependence
  2. Respiratory depression (respiration has a rate below 12 breaths)
  3. Drug ineffective
  4. Dyspnoea (difficult or laboured respiration)
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Exostosis (formation of new bone on the surface of a bone)
  7. Gait disturbance
  8. Hepatic enzyme increased
  9. International normalised ratio increased
  10. Localised infection (infection at the single location)

What are the common drug interactions of Dulcolax and Catapres, by age (0-1 to 60+)? *:

0-1:

  1. Acute respiratory failure
  2. Catheter site discharge
  3. Catheter site haemorrhage (bleeding at catheter site)
  4. Catheter site pain
  5. Catheter site swelling
  6. Feeling hot
  7. Flushing (the warm, red condition of human skin)
  8. Infusion site pain
  9. Pyrexia (fever)
  10. Tracheostomy malfunction (a surgical opening of trachea not working normally)

2-9:

n/a

10-19:

  1. Drug dependence
  2. Respiratory depression (respiration has a rate below 12 breaths)
  3. Child abuse
  4. Diarrhoea
  5. Drug ineffective
  6. Weight decreased
  7. Drug abuse
  8. Epidural lipomatosis (excessive accumulation of fat within the epidural space -brain)
  9. Juvenile idiopathic arthritis (a subset of arthritis seen in childhood)
  10. Obesity (having too much body fat)

20-29:

  1. Complication of device insertion

30-39:

n/a

40-49:

  1. Abscess (pus)
  2. Blood creatinine increased
  3. Exostosis (formation of new bone on the surface of a bone)
  4. International normalised ratio increased
  5. Localised infection (infection at the single location)
  6. Muscular weakness (muscle weakness)
  7. Post procedural haemorrhage (post procedural bleeding)
  8. Skin ulcer
  9. Acute respiratory failure
  10. Alanine aminotransferase increased

50-59:

  1. Joint contracture (a permanent shortening of a muscle or joint)
  2. Joint stiffness
  3. Mobility decreased (ability to move is reduced)
  4. Muscular weakness (muscle weakness)
  5. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  6. Oedema peripheral (superficial swelling)
  7. Pain
  8. Pain of skin
  9. Paralysis
  10. Rash macular (small, flat red spots)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Anxiety
  3. Gastritis (inflammation of stomach)
  4. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  5. Muscular weakness (muscle weakness)
  6. Neoplasm malignant (cancer tumour)
  7. Pain
  8. Respiratory disorder (respiratory disease)
  9. Urinary retention (the inability to completely or partially empty the bladder)
  10. Abscess oral (abscess in the mouth)

What are the existing conditions these people have? *

  1. Pain: 17 people, 27.87%
  2. Nausea (feeling of having an urge to vomit): 12 people, 19.67%
  3. Stress And Anxiety: 11 people, 18.03%
  4. Metastases To Bone (cancer spreads to bone): 9 people, 14.75%
  5. Diabetes: 8 people, 13.11%
  6. Wheezing (a high-pitched whistling sound made while you breath): 7 people, 11.48%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 9.84%
  8. Anaemia (lack of blood): 6 people, 9.84%
  9. Nausea And Vomiting: 6 people, 9.84%
  10. Muscle Spasms (muscle contraction): 5 people, 8.20%

* Approximation only. Some reports may have incomplete information.

Do you take Dulcolax and Catapres?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dulcolax and Catapres:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dulcolax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Catapres:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dulcolax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Catapres and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bisacodyl and clonidine hydrochloride (the active ingredients of Dulcolax and Catapres, respectively), and Dulcolax and Catapres (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: